Sandoz Expands Recall of Cefazolin Vials Over Labeling Error

TL;DR Summary
Sandoz has expanded a nationwide recall of one lot of Cefazolin for Injection after discovering some vials were mislabeled as Penicillin G Potassium, which could pose serious health risks if administered. No adverse events have been reported, but the company is urging healthcare providers and customers to stop using the affected product and return it.
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
5 min
vs 6 min read
Condensed
95%
1,093 → 55 words
Want the full story? Read the original article
Read on fda.gov